
Nothing remains concealed. Exploring long #noncoding #RNAs in #cancer. Founded by @oncogenie
Joined October 2020
- Tweets53
- Following37
- Followers185
- Likes68
Pinned Tweet
We are honored to be featured in the top 5 of NZ's hottest biotech startups! Big thanks to @businessdesk_nz
businessdesk.co.nz/article/t…
Thanks so much for including us in this panel!
#QRW2023
Great to moderate the Research Commercialisation workshop @QTResearchWeek supported by @otago Centre for Bioengineering with expert panel: Sarah Diermeier @amaroqtx Elliot Dunn #brandoncapital Kathleen Lucere #EvenCapital Sam Wilkins @OtagoInnovation Azam Ali @otago @MedtechNZ
5
371
Exciting updates on AURORA our oncology target ID platform!
Check out our webpage and LinkedIn for details linkedin.com/posts/amaroqtx_…
2
178
Amaroq Therapeutics retweeted
Interesting talk by Sarah Diermeier from @amaroqtx on developing a new class of therapeutics that target long non-coding RNAs in cancer
#ShineDalgarnoCentre #ANURNA2023 #SDCRI @JCSMR
Great to see our Founder and CSO Sarah Diermeier featured for #WomensHistoryMonth in @NatureBiotech!
For #WomensHistoryMonth, we're celebrating outstanding scientists in the biotech industry. We salute Sarah Diermeier, founder and chief scientific officer of Amaroq Therapeutics, which is focused on developing a new class of therapeutics that target long non-coding RNAs in cancer
3
246
As another recent addition to the team, we are welcoming @KLucere!
Kat comes with a deep tech background (cancer research and neurobiology) in both US and NZ science ecosystems. She is now doing a stellar job supporting our BD efforts.
We are so excited to have you Kat!
Amaroq Therapeutics retweeted
So excited to have joined the team and be working on this amazing technology!
We made some recent additions to our team!
We were lucky to recruit the amazing @MMROMalley, an RNA Tx and oncology expert, to lead our in vitro TIDVAL efforts.
Welcome Meg, we look forward to developing the next generation of cancer drugs together!
Amaroq Therapeutics retweeted
Grateful to have had the opportunity to attend and present my research at #cshlcancer22 this past week.
Met some amazing people, heard about fantastic science and ofc the highlight was the famous CSHL lobster!! 🦞
We made some recent additions to our team!
We were lucky to recruit the amazing @MMROMalley, an RNA Tx and oncology expert, to lead our in vitro TIDVAL efforts.
Welcome Meg, we look forward to developing the next generation of cancer drugs together!
Amaroq Therapeutics retweeted
Join us next Monday at a @BIOTechNZ event in Dunedin!
I‘ll be speaking about @amaroqtx alongside the CEO of @PacificEdgeLtd and others in the local biotech sphere
BioTechNZ is proud to announce its next Connect event, Understanding Dunedin’s Flourishing Biotech Ecosystem. Hear from established and start-up companies, learn about their growth and hear how they are accessing funding.ow.ly/uuuE50JzKlg
@otago biotechnz.org.nz/event/under…
We are thrilled to announce our recent progress towards the next generation of RNA therapeutics in oncology.
We were also fortunate to assemble a stellar Scientific Advisory Board that will guide us on our path to the clinic!
prnewswire.com/news-releases…
R&D team photo with our Operations Manager Dr Nadine Brew (right), who visited us this week from Melbourne.
Had two productive days of strategic planning to map out the next 12 month’s of our RNA therapeutics development program. Exciting times ahead!
We have some exciting job opportunities coming up🤩
If you are keen to develop the next generation of RNA therapeutics for oncology, please get in touch!
Amaroq Therapeutics retweeted
Research leader pushes nanomedicine hub in NZ ift.tt/tF9Dorj
New Zealand should become a nanomedicine production hub, says an up-and-coming commercial researcher based here at Otago Biochemistry.
Dr Sarah Diermeier, Rutherford Discovery Fellow and senior lecturer, ma…
Amaroq Therapeutics retweeted
Oped by myself and the brilliant Kylie Price, CTO of @Malaghan_Inst on how recent technological advancements in mRNA vaccines and the RNA therapeutics space can benefit the NZ economy
nbr.co.nz/node/234003
Huge congrats to @allPowerde!!
Here's what @allPowerde had to say about winning the AI in Innovation award at last night's @women_in_ai awards. 🏆🥳
#cloudcomputing #cloud #AI
2
Fantastic collaboration with @allPowerde @ehealthresearch!
A great story about how we boosted product confidence of a world-leading #RNA therapeutics start-up, @amaroqtx.
#healthdata #PrecisionMedicine #CancerResearch
https://nitter.cf/t.co/nG9L44rvVd
@TBioinf @allPowerde
Amaroq Therapeutics retweeted
Excited to share that Eclipsebio (co-founded by our lab alums @EVanNostrandLab and Alex Shishkin) announces a $14 Million Series A Financing to Advance Its RNA Genomics Technology Platform prn.to/34IZqSG
Did you know that women make up at least 50% of our team on all levels, from R&D to management, BoD and SAB?
On #InternationalWomenInScienceDay and everyday, we celebrate the incredible women that drive our research!
#WomenInSTEM #WomeninScienceDay






















